VTAK Stock Catalyst: Catheter Precision's LockeT Gains UK Approval Following EU Success

Aug 18, 2025 · 8:00am ET

The approval follows the device's successful clearance in the European Union.

Max move

+105.5%

High of day $5.28

Sparker timei

8:00am ET

VTAK · Aug 18, 2025

CATALYST DATE · 1-MINUTE BARS

Catalyst Summary

Catheter Precision, Inc. (NYSE: VTAK) announced that its LockeT device has received approval in the United Kingdom. This follows the device's successful clearance and market introduction in the European Union.

The LockeT device is designed to enhance the stability and performance of catheters used in various medical procedures. The UK approval expands the device's market reach, allowing Catheter Precision to target additional healthcare providers and patients in the region.

This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.

Real-time alerts

Get notified the next time VTAK sparks.

Download Sniper App →

Catch the next VTAK-style move in real time.

Day Trader Sniper alerts you the moment a setup like this triggers: premarket, open, or intraday.

Watch demo Download Free →